By Metro US
Posted on
(Reuters) – Pfizer Inc said on Monday that it had enrolled more than 29,000 people in its 44,000-volunteer trial to test the experimental COVID-19 vaccine it is developing with German partner BioNTech.
The company, which expanded the size of the trial from 30,000 people over the weekend, had enrolled more than 25,000 people as of last week. The company has said it could have results on whether the vaccine works in October.
(Reporting by Michael Erman, Editing by Franklin Paul)
Luka Doncic and Kyrie Irving lead Mavs over Clippers 96-93 to tie series as Kawhi Leonard returns
Pacers’ Haliburton says fan directed racial slur at his younger brother during playoff game
Pascal Siakam leads resurgent Pacers offense in 125-108 victory that evens series with Bucks
Timberwolves take 2-0 lead on Suns behind 25 points and ace defense from Jaden McDaniels
Vincent Trocheck and Mika Zibanejad lead Rangers to 4-3 win over Capitals for 2-0 series lead
London police contain 2 horses that were on the loose in the city. It’s still a mystery as to why
TikTok may be banned in the US. Here’s what happened when India did it
Ukrainian officials thank the US for its latest military aid to help stop Russia’s onslaught
Arrests follow barricades and encampments as college students nationwide protest Gaza war
Australian police arrest 7 alleged teen extremists linked to stabbing of a bishop in a Sydney church
Remnants of bird flu virus found in pasteurized milk, FDA says
Mississippi lawmakers haggle over possible Medicaid expansion as their legislative session nears end
US health officials warn of counterfeit Botox injections
Ashley Judd and Aloe Blacc help the White House unveil its national suicide prevention strategy
